<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20120915010841N28</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-20</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>Post injection Propofol pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of intravenous administration of low-dose Propofol with lidocaine on the reduction of local pain caused by intravenous injection of full-dose Propofol during induction of general anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>88</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/90878</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, we will use the quadruple Block Randomization method. For this purpose, we prepare four sheets of paper.Write the letter A on two sheets and the letter B on the other two sheets. Mix the sheets together and place them in the desk drawer. With the referral of each eligible patient, one of the sheets is randomly taken out and based on this sheet is A or B, it will be assigned to one of the two groups of Propofol  or Lidocaine. After randomly pulling out all four sheets, all the papers are returned to the drawer and the above procedure will be continued for the next four patients until the desired sample size is reached, Blinding description: After inserting a size 20 angiocatheter into the patient's hand and receiving 5ml/kg of Ringer's solution, the patient's hand will be held up for 10 seconds, then the top of the angiocatheter will be blocked with a tourniquet, and  on the randomization block, one of two drugs, Lidocaine (40 mg) or Propofol (20 mg), will be injected by the anesthesiologist. in syringes of the same shape and volume, covered with cloth tape, and numbered by the nurse anesthetist (who is unaware of the details of the design).</study_design>
      <phase>2-3</phase>
      <hc_freetext>Pain reduction from intravenous injection of full dose of propofol.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After entering the operating room, a 20-gauge angiocatheter is first fixed in the veins on the back of the patient's hand. After receiving 5 ml/kg of Ringer's serum, the patient's hand is held up for 10 seconds and then the upper part of the angiocatheter is blocked with a tourniquet, and then lidocaine (40 mg) is injected by the anesthesiologist through the same angiocatheter. After 2 minutes, the vein is opened and ¼ of the induction dose of propofol (0.5 mg/kg) is injected by the anesthesiologist through the same vein. Then, the intensity of pain in the patient's hand during the injection of propofol is assessed based on the visual scale of pain(VAS)  and recorded in a questionnaire. Then, anesthesia induction is completely performed by injecting 2 ug/kg of fentanyl and the remaining dose of propofol (1.5 mg/kg) and 0.5 mg/kg of atracurium, and after 3 minutes, intubation will be performed. Intervention 2: Intervention group:  After entering the operating room, a 20-gauge angiocatheter is first fixed in the veins on the back of the patient's hand. After receiving 5 ml/kg of Ringer's serum, the patient's hand is held up for 10 seconds and then the upper part of the angiocatheter is blocked with a tourniquet, and then propofol (20 mg) is injected by the anesthesiologist through the same angiocatheter. After 2 minutes, the vein is opened and ¼ of the induction dose of propofol (0.5 mg/kg) is injected by the anesthesiologist through the same vein. Then, the intensity of pain in the patient's hand during the injection of propofol is assessed based on the visual scale of pain(VAS) and recorded in a questionnaire. Then, anesthesia induction is completely performed by injecting 2 ug/kg of fentanyl and the remaining dose of propofol (1.5 mg/kg) and atracurium 0.5 mg/kg, and intubation will be performed after 3 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Because the study is not finished yet.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nahid Manouchehrian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Besat Hospital, Modafeane salamat St, Beheshti Blvd,</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517789971</zip>
        <telephone>+98 81 3264 0030</telephone>
        <email>manuchehriann@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nahid  Manouchehrian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Besat Hospital, Modafeane salamat St, Beheshti Blvd</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838678</zip>
        <telephone>+98 81 3264 0030</telephone>
        <email>manuchehriann@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged from 18 to 60 years old
ASA class 1 and 2
Candidate for  elective surgery under general anesthesia</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of cardiovascular disease
History of seizure
Consumption history of narcotics, sedatives and anti anxiety drugs
Previous allergy to egg and peanut
Previous allergy to Propofol and lidocaine
Infection or wound on dorsal  of hand</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Y48.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Drugs, medicaments and biological substances causing adverse effects in therapeutic use</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After entering the operating room, a 20-gauge angiocatheter is first fixed in the veins on the back of the patient's hand. After receiving 5 ml/kg of Ringer's serum, the patient's hand is held up for 10 seconds and then the upper part of the angiocatheter is blocked with a tourniquet, and then lidocaine (40 mg) is injected by the anesthesiologist through the same angiocatheter. After 2 minutes, the vein is opened and ¼ of the induction dose of propofol (0.5 mg/kg) is injected by the anesthesiologist through the same vein. Then, the intensity of pain in the patient's hand during the injection of propofol is assessed based on the visual scale of pain(VAS)  and recorded in a questionnaire. Then, anesthesia induction is completely performed by injecting 2 ug/kg of fentanyl and the remaining dose of propofol (1.5 mg/kg) and 0.5 mg/kg of atracurium, and after 3 minutes, intubation will be performed.</i_keyword>
      <i_keyword>Intervention group:  After entering the operating room, a 20-gauge angiocatheter is first fixed in the veins on the back of the patient's hand. After receiving 5 ml/kg of Ringer's serum, the patient's hand is held up for 10 seconds and then the upper part of the angiocatheter is blocked with a tourniquet, and then propofol (20 mg) is injected by the anesthesiologist through the same angiocatheter. After 2 minutes, the vein is opened and ¼ of the induction dose of propofol (0.5 mg/kg) is injected by the anesthesiologist through the same vein. Then, the intensity of pain in the patient's hand during the injection of propofol is assessed based on the visual scale of pain(VAS) and recorded in a questionnaire. Then, anesthesia induction is completely performed by injecting 2 ug/kg of fentanyl and the remaining dose of propofol (1.5 mg/kg) and atracurium 0.5 mg/kg, and intubation will be performed after 3 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Local Pain Score. Timepoint: After injection of 1/4 of Propofol dose. Method of measurement: Visual analog scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Systolic &amp; Diastolic  Blood Pressure. Timepoint: Before and after injection of 1/4 dose of propofol, After injection of full dose of propofol and before &amp; after intubation. Method of measurement: Automatic non-invasive blood pressure monitor.</sec_outcome>
      <sec_outcome>Mean Arterial Pressure. Timepoint: Before and after injection of 1/4 dose of propofol, After injection of full dose of propofol and before &amp; after intubation. Method of measurement: Automatic non-invasive blood pressure monitor.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: Before and after injection of 1/4 dose of propofol, After injection of full dose of propofol and before &amp; after intubation. Method of measurement: Pulse Oximetry.</sec_outcome>
      <sec_outcome>Amount of ephedrine and atropine used. Timepoint: During the operation. Method of measurement: Milligram.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-25</approval_date>
        <contact_name>Ethics committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>Mahdieh Street, Hamadan University of Medical Sciences Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
